With the biotech sector's battle for cash getting fiercer, Ireland's Priothera Limited has tapped into the considerable resources of the European Investment Bank (EIB) to get financing for a late-stage study of its promising blood cancer candidate mocravimod.
As Biotech Cash Dries Up, Ireland's Priothera Gets EU Backing For Leukemia Drug
€17.5m Loan From European Investment Bank
At a time when the sector has fallen out of favor with venture capitalists and public markets, Irish biotech Priothera is accessing funds from the EU to advance a Phase IIb/III study of mocravimod for acute myeloid leukemia patients receiving hematopoietic stem cell transplants.
